{"id":906,"date":"2023-08-08T11:16:35","date_gmt":"2023-08-08T11:16:35","guid":{"rendered":"https:\/\/amm-journal.org\/?p=906"},"modified":"2023-08-08T11:16:35","modified_gmt":"2023-08-08T11:16:35","slug":"recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality","status":"publish","type":"post","link":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/","title":{"rendered":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality"},"content":{"rendered":"

Announcing a new publication for Acta Materia Medica<\/em> journal. Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the emergence of drug resistance. Among the protein degradation-based multi-specific approaches, proteolysis targeting chimera (PROTAC) is the main strategy applied in the antiviral field. In this article the authors discuss the elements and mechanisms of action used by PROTAC technology, as well as the advantages of PROTACs over available antiviral drugs. The latest progress in the application of PROTACs in antiviral research, existing challenges and future opportunities for antiviral drug discovery are also discussed.<\/p>\n

https:\/\/www.scienceopen.com\/hosted-document?doi=10.15212\/AMM-2023-0019<\/a><\/p>\n

Acta Materia Medica<\/em> welcomes the submission of research articles, review articles, databases, mini reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\n

Submission Process<\/strong><\/p>\n

Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a><\/p>\n

Queries about the journal can be sent to editorialoffice@amm-journal.org.<\/p>\n

Please visit https:\/\/amm-journal.org\/<\/a> to learn more about the journal.<\/p>\n

Editorial Board:<\/strong> https:\/\/amm-journal.org\/index.php\/editorial-board\/<\/a><\/p>\n

There are no author submission or article processing fees.<\/p>\n

Follow Acta Materia Medica <\/em><\/strong>on Twitter https:\/\/twitter.com\/AMM_journal<\/a>\u00a0 https:\/\/twitter.com\/ZoonosesJ<\/a>; Facebook<\/a> (https:\/\/www.facebook.com\/AMMjournal<\/a>)<\/p>\n

eISSN <\/strong>2737-7946<\/p>\n

Yang Zhou, Shujing Xu and Nerea L\u00f3pez-Carrobles et al. Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality.\u00a0Acta Materia Medica.\u00a0<\/em>2023. Vol. 2(3):285-298. DOI: 10.15212\/AMM-2023-0019<\/p>\n","protected":false},"excerpt":{"rendered":"

Announcing a new publication for Acta Materia Medica journal. Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[209,13,208],"class_list":["post-906","post","type-post","status-publish","format-standard","hentry","category-news-and-events","tag-antiviral-drugs","tag-protac","tag-viral-infections"],"yoast_head":"\nRecent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal\" \/>\n<meta property=\"og:description\" content=\"Announcing a new publication for Acta Materia Medica journal. Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/\" \/>\n<meta property=\"og:site_name\" content=\"AMM Journal\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-08T11:16:35+00:00\" \/>\n<meta name=\"author\" content=\"Compuscript\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Compuscript\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/\"},\"author\":{\"name\":\"Compuscript\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"headline\":\"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality\",\"datePublished\":\"2023-08-08T11:16:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/\"},\"wordCount\":299,\"commentCount\":0,\"keywords\":[\"antiviral drugs\",\"PROTAC\",\"Viral infections\"],\"articleSection\":[\"News and Events\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/\",\"name\":\"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\"},\"datePublished\":\"2023-08-08T11:16:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/2023\\\/08\\\/08\\\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/amm-journal.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#website\",\"url\":\"https:\\\/\\\/amm-journal.org\\\/\",\"name\":\"AMM Journal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/amm-journal.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/amm-journal.org\\\/#\\\/schema\\\/person\\\/0935dba5c919585e39f756ce09930a67\",\"name\":\"Compuscript\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g\",\"caption\":\"Compuscript\"},\"sameAs\":[\"https:\\\/\\\/amm-journal.org\"],\"url\":\"https:\\\/\\\/amm-journal.org\\\/index.php\\\/author\\\/ammjadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/","og_locale":"en_GB","og_type":"article","og_title":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal","og_description":"Announcing a new publication for Acta Materia Medica journal. Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the […]","og_url":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/","og_site_name":"AMM Journal","article_published_time":"2023-08-08T11:16:35+00:00","author":"Compuscript","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Compuscript","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/#article","isPartOf":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/"},"author":{"name":"Compuscript","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"headline":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality","datePublished":"2023-08-08T11:16:35+00:00","mainEntityOfPage":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/"},"wordCount":299,"commentCount":0,"keywords":["antiviral drugs","PROTAC","Viral infections"],"articleSection":["News and Events"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/","url":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/","name":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality - AMM Journal","isPartOf":{"@id":"https:\/\/amm-journal.org\/#website"},"datePublished":"2023-08-08T11:16:35+00:00","author":{"@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67"},"breadcrumb":{"@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/amm-journal.org\/index.php\/2023\/08\/08\/recent-advances-in-the-molecular-design-and-applications-of-proteolysis-targeting-chimera-based-multi-specific-antiviral-modality\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/amm-journal.org\/"},{"@type":"ListItem","position":2,"name":"Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality"}]},{"@type":"WebSite","@id":"https:\/\/amm-journal.org\/#website","url":"https:\/\/amm-journal.org\/","name":"AMM Journal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/amm-journal.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/amm-journal.org\/#\/schema\/person\/0935dba5c919585e39f756ce09930a67","name":"Compuscript","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fb3d42af3c1b48f4d76adf5524c6c3447a369d2a7bcb666ef995240441912a6b?s=96&d=mm&r=g","caption":"Compuscript"},"sameAs":["https:\/\/amm-journal.org"],"url":"https:\/\/amm-journal.org\/index.php\/author\/ammjadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/906","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/comments?post=906"}],"version-history":[{"count":1,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/906\/revisions"}],"predecessor-version":[{"id":907,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/posts\/906\/revisions\/907"}],"wp:attachment":[{"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/media?parent=906"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/categories?post=906"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/amm-journal.org\/index.php\/wp-json\/wp\/v2\/tags?post=906"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}